University Medical Center of Southern Nevada
Board of Hospital Trustees
AGENDA ITEM
Petitioner:
Mason Van Houweling, Chief Executive Officer
Recommendation:
title
Approve and authorize the Chief Executive Officer to sign the Agreement for Histocompatibility Testing Services with Nevada Donor Network, Inc.; or take other action as appropriate. (For possible action)
body
FISCAL IMPACT:
Fund #:
5420.000
Fund Name:
UMC Operating Fund
Fund Center:
Various
Funded PGM/Grant:
N/A
Amount:
$7,500,000 per year
Description:
Histocompatibility Testing Services
Additional Comments:
60-day termination without cause provision
BACKGROUND:
As a transplant hospital, UMC is mandated to provide and acquire the services of a properly licensed and approved histocompatibility laboratory to perform tests on the blood of prospective transplant patients. These tests are required to determine the compatibility of antigens of the donor and recipient before tissue transplantation. This request is to approve a new agreement with Nevada Donor Network, Inc. (NDN) to provide histocompatibility testing services to UMC. The contract is for one (1) base year with four (4), one (1) year renewal years, unless earlier terminated with a 60-day written notice. In accordance with NRS 332.115(1)(a), this service is sole source. NDN is the sole CMS authorized provider of this service in Southern Nevada. All pricing is set by CMS under Medicare# 29-HL01. UMC’s Director of Transplant Services has reviewed the Agreement and recommends approval by UMC’s Board of Hospital Trustees. The Agreement has been approved as to form by UMC’s Office of General Counsel.NDN currently holds a Clark County Business License. This Agreement was reviewed by the UMC Governing Board at their January 31, 2024 meeting and recommended for approval by the Board of Hospital Trustees.